Stage IIIA Skin Melanoma Active Not Recruiting Phase 2 Trials for Aflibercept (DB08885)

IndicationStatusPhase
DBCOND0029533 (Stage IIIA Skin Melanoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs